Advance Search

Validation of HIV risk screening tool to identify infected adults and adolescents >14 years at community Level

Kesetebirhan Delele
Family Health International, Ethiopia
Justin Mandala | Bio
Family Health International, Washington DC, USA
Keywords:
Copyright and Licensing:

Copyright (c) 2023 Ethiopian Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Share:
  • Articles
  • Submited: October 18, 2022
  • Published: January 2, 2023

Abstract

Introduction: There are several risk factors being used to identify undiagnosed HIV-infected adults. As the number of undiagnosed people gets less and less, it is important to know if existing risk factors and risk assessment tools are valid for use.

Methods:  Data from the Tanzania and Zambia Population-Based HIV Impact Assessment (PHIA) household surveys which were conducted during 2016 was used. We first included 12 risk factors (being divorced, separated or widowed; having an HIV+ spouse; having one of the following within 12-months of the survey: paid work, slept away from home for ≥1-month, having multiple sexual partners, clients of sex workers, sexually transmitted infection, being tuberculosis suspect, being very sick for ≥3-months; ever sold sex; diagnosed with cervical cancer; and had TB disease into a risk assessment tool and assessed its validity by comparing it against HIV test result. Sensitivity, specificity and predictive value of the tool were assessed. Receiver Operating Characteristic (ROC) curve comparison statistics was also used to determine which risk assessment tool was better.

Results: HIV prevalence was 2.3% (2.0%-2.6%) (n=14,820). For the tool containing all risk factors, HIV prevalence was 1.0% when none of the risk factors were present (Score 0) compared to 3.2% when at least one factor (Score ≥1) was present and 8.0% when ≥4 risk factors were present. Sensitivity, specificity, PPV, and NPV were 82.3% (78.6%-85.9%), 41.9%(41.1%-42.7%), 3.2%(2.8%-3.6%), and 99.0%(98.8%-99.3%), respectively. The use of a tool containing conventional risk factors (all except those related with working and sleeping away) was found to have higher AUC (0.65 vs 0.61) compared to the use of all risk factors (p value <0.001).

Conclusions: The use of a screening tool containing conventional risk factors improved HIV testing yield compared to doing universal testing. Prioritizing people who fulfill multiple risk factors should be explored further to improve HIV testing yield.

 

PDF
PDF

Downloads

Download data is not yet available.

References

  1. World Health Organization: WHO Guidelines on HIV Testing. 2015.
  2. World Health Organization: Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment And Care For Key Populations. 2016.
  3. World Health Organization: Consolidated HIV Prevention, Care and Treatment Guideline. 2016.
  4. UNAIDS: AIDS Info: Progress towards 90-90-90 targets (https://aidsinfo.unaids.org/). 2020.
  5. ICF: The DHS Program STATcompiler. http://www.statcompiler.com. August 6 2020. 2020.
  6. Maheu-Giroux M, Marsh K, Doyle CM, Godin A, Delaunay CL, Johnson LF, Jahn A, Abo K, Mbofana F, Boily M-C: National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the ‘first 90’from program and survey data. AIDS (London, England) 2019, 33(Suppl 3):S255.
  7. KFF: U.S. Federal Funding for HIV/AIDS: Trends Over Time (from: https://www.kff.org/hivaids/fact-sheet/u-s-federal-funding-for-hivaids-trends-over-time/). Accessed on August 7, 2020. 2020.
  8. Shanaube K, Schaap A, Floyd S, Phiri M, Griffith S, Chaila J, Bock P, Hayes R, Fidler S, Ayles H: What works–reaching universal HIV testing: lessons from HPTN 071 (PopART) trial in Zambia. AIDS (London, England) 2017, 31(11):1555.
  9. PEPFAR: Annual Report to Congress. 2019.
  10. Balkus JE, Brown E, Palanee T, Nair G, Gafoor Z, Zhang J, Richardson BA, Chirenje ZM, Marrazzo JM, Baeten JM: An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women. Journal of acquired immune deficiency syndromes (1999) 2016, 72(3):333.
  11. Birri Makota RB, Musenge E: Factors associated with HIV infection in Zimbabwe over a decade from 2005 to 2015: an interval-censoring survival analysis approach. Frontiers in public health 2019, 7:262.
  12. Ba DM, Ssentongo AE, Traore M, Ssentongo P: Prevalence of Human Immunodeficiency Virus and Its Sociodemographic, Knowledge and Behavioral Predictors among Women: A Cross‐Sectional Population‐Based Survey in Ivory Coast. of 2018, 6:2011-2012.
  13. Fauk NK, Kustanti CY, Wulandari R, Damayani AD, Mwanri L: Societal determinants of HIV vulnerability among clients of female commercial sex workers in Indonesia. PloS one 2018, 13(11):e0207647.
  14. Wu ES, Urban RR, Krantz EM, Mugisha NM, Nakisige C, Schwartz SM, Gray HJ, Casper C: The association between HIV infection and cervical cancer presentation and survival in Uganda. Gynecologic oncology reports 2020, 31:100516.
  15. Dalal S, Johnson C, Fonner V, Kennedy CE, Siegfried N, Figueroa C, Baggaley R: Reaching people with undiagnosed HIV infection through assisted partner notification. AIDS (London, England) 2017, 31(17):2436.
  16. Smith DK, Pan Y, Rose CE, Pals SL, Mehta SH, Kirk GD, Herbst JH: A brief screening tool to assess the risk of contracting HIV infection among active injection drug users. Journal of addiction medicine 2015, 9(3):226.
  17. Haukoos JS, Hopkins E, Bucossi MM, Lyons MS, Rothman RE, White DA, Al-Tayyib AA, Bradley-Springer L, Campbell JD, Sabel AL: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort. Journal of acquired immune deficiency syndromes (1999) 2015, 68(5):599.
  18. Ministry of Health Z: Zambia Population-based HIV Impact Assessment (ZAMPHIA) 2016: Final Report. Lusaka. 2019.
  19. (ZAC). TCfATZAC: Tanzania HIV Impact Survey (THIS) 2016-2017: Final Report. Dar es Salaam, Tanzania. 2018.
  20. Population-based HIV Impact Assessment (PHIA) Data Use Manual. NewYork NJ.
  21. MedCalcStatisticalSoftwareversion19.4.1(MedCalcSoftware Ltd -O, -Belgium; https://www.medcalc.org;2020).
  22. The PHIA Project: Population-Based HIV Impact Assessment Datasets (accessed from: https://phia-data.icap.columbia.edu/files). 2020.
  23. Chanda MM, Ortblad KF, Mwale M, Chongo S, Kanchele C, Kamungoma N, Fullem A, Dunn C, Barresi LG, Harling G: HIV self-testing among female sex workers in Zambia: a cluster randomized controlled trial. PLoS medicine 2017, 14(11):e1002442.
  24. Mwango L, Mujansi M, Chipukuma J, Phiri B, Sakala H, Nyirongo N, Sivile S, Sinjani M, Lavoie M-C, Claassen C: Reaching the unreachable: early results from index testing in Zambia in the CIRKUITS project. In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY: 2019: JOHN WILEY & SONS LTD THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W …; 2019: 13-14.
  25. Ministry of Health: National Comprehensive HIV Prevention, Care and Treatment Training for Health care Providers. 2017.
  26. Ministry of Health: The Kenya HIV Testing Services Guidelines (from http://www.hivst.org/files1/kenyahtsguidelines20151-160119080906.pdf). 2015.
  27. Mayo Foundation for Medical Education and Research: Cervical cancer: symptoms and cause (from: https://www.mayoclinic.org/diseases-conditions/cervical-cancer/symptoms-causes/syc-20352501). 2020.
  28. Zambia Statistics Agency - ZSA, Ministry of Health - MOH, University Teaching Hospital Virology Laboratory - UTH-VL, ICF: Zambia Demographic and Health Survey 2018. In. Lusaka, Zambia: ZSA, MOH, UTH-VL and ICF; 2020.
  29. Ministry of Health CD, Gender, Elderly, Children - MoH CDGEC/Tanzania Mainland, Ministry of Health - MoH/Zanzibar, National Bureau of Statistics - NBS/Tanzania, Office of Chief Government Statistician - OCGS/Zanzibar, ICF: Tanzania Demographic and Health Survey and Malaria Indicator Survey 2015-2016. In. Dar es Salaam, Tanzania: MoH CDGEC, MoH, NBS, OCGS, and ICF; 2016.
  30. Yotebieng M, Wenzi LK, Basaki E, Batumbula ML, Tabala M, Mungoyo E, Mangala R, Behets F: Provider-Initiated HIV testing and counseling among patients with presumptive tuberculosis in Democratic Republic of Congo. The Pan African Medical Journal 2016, 25.
  31. Kyaw KWY, Kyaw NTT, Kyi MS, Aye S, Harries AD, Kumar AM, Oo NL, Satyanarayana S, Aung ST: HIV testing uptake and HIV positivity among presumptive tuberculosis patients in Mandalay, Myanmar, 2014-2017. PloS one 2020, 15(6):e0234429.
  32. Delany-Moretlwe S, Bello B, Kinross P, Oliff M, Chersich M, Kleinschmidt I, Rees H: HIV prevalence and risk in long-distance truck drivers in South Africa: a national cross-sectional survey. International journal of STD & AIDS 2014, 25(6):428-438.
  33. Botão C, Horth RZ, Frank H, Cummings B, Inguane C, Sathane I, McFarland W, Raymond HF, Young PW: Prevalence of HIV and associated risk factors among long distance truck drivers in Inchope, Mozambique, 2012. AIDS and Behavior 2016, 20(4):811-820.
How to Cite
Delele, K., & Mandala, J. (2023). Validation of HIV risk screening tool to identify infected adults and adolescents >14 years at community Level. Ethiopian Medical Journal, 61(1). Retrieved from https://emjema.org/index.php/EMJ/article/view/2257

Send mail to Author

Send Cancel